ATXN2 and Ataxia: Other key issues deserving special attention in future researches are the pathogenetic link between ATXN2 intermediate expansions and other neurodegenerative disease, such as ALS, which challenges the genetic testing for CAG repeat expansions in this gene as patients with ataxia and a family history of ALS.